These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36265370)

  • 1. Construction and expression of Mycobacterium tuberculosis fusion protein AR2 and its immunogenicity in combination with various adjuvants to form vaccine.
    Wang X; Du J; Zhang Y; Zhu T; Mao L; Xu L; Shi Z; Zhang J; Sun Q; Qi Z; Xia L
    Tuberculosis (Edinb); 2022 Dec; 137():102270. PubMed ID: 36265370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and expression of Mycobacterium tuberculosis fusion protein SHR3 and its immunogenicity analysis in combination with various adjuvants.
    Zhang Z; Xu L; Wang X; Kong L; Shi Z; Zhong Q; Xu Y; Wang J
    Tuberculosis (Edinb); 2024 Mar; 145():102480. PubMed ID: 38278100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-γ+ IL-2+ CD4+ and IFN-γ+ CD8+ T cells.
    Wang X; Zhang J; Liang J; Zhang Y; Teng X; Yuan X; Fan X
    PLoS One; 2015; 10(3):e0122560. PubMed ID: 25822536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenic profiling of Mycobacterium tuberculosis Rv1513 reveals its ability to switch on Th1 based immunity.
    Shi Z; Zhou L; Wang X; Zhang Z; Kong L; Zhang Y
    Arch Microbiol; 2024 Jul; 206(8):352. PubMed ID: 39012499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly persistent and effective prime/boost regimens against tuberculosis that use a multivalent modified vaccine virus Ankara-based tuberculosis vaccine with interleukin-15 as a molecular adjuvant.
    Kolibab K; Yang A; Derrick SC; Waldmann TA; Perera LP; Morris SL
    Clin Vaccine Immunol; 2010 May; 17(5):793-801. PubMed ID: 20357059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Immunogenicity and
    Mao LR; Du JP; Wang XC; Xu LF; Zhang YP; Sun QS; Shi ZL; Xing YR; Su YX; Wang SJ; Wang J; Ma JL; Zhang JY
    ACS Infect Dis; 2023 Mar; 9(3):593-608. PubMed ID: 36808986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and protective efficacy of DMT liposome-adjuvanted tuberculosis subunit CTT3H vaccine.
    Teng X; Tian M; Li J; Tan S; Yuan X; Yu Q; Jing Y; Zhang Z; Yue T; Zhou L; Fan X
    Hum Vaccin Immunother; 2015; 11(6):1456-64. PubMed ID: 25905680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The secreted lipoprotein, MPT83, of Mycobacterium tuberculosis is recognized during human tuberculosis and stimulates protective immunity in mice.
    Kao FF; Mahmuda S; Pinto R; Triccas JA; West NP; Britton WJ
    PLoS One; 2012; 7(5):e34991. PubMed ID: 22567094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the fusion design and immunization route on the immunogenicity of Ag85A-Mtb32 in adenoviral vectored tuberculosis vaccine.
    Zhang Y; Feng L; Li L; Wang D; Li C; Sun C; Li P; Zheng X; Liu Y; Yang W; Niu X; Zhong N; Chen L
    Hum Vaccin Immunother; 2015; 11(7):1803-13. PubMed ID: 26076321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant bacille Calmette-Guerin coexpressing Ag85b, CFP10, and interleukin-12 elicits effective protection against Mycobacterium tuberculosis.
    Chen YY; Lin CW; Huang WF; Chang JR; Su IJ; Hsu CH; Cheng HY; Hsu SC; Dou HY
    J Microbiol Immunol Infect; 2017 Feb; 50(1):90-96. PubMed ID: 25732698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and Protective Efficacy of a Fusion Protein Tuberculosis Vaccine Combining Five Esx Family Proteins.
    Xiang ZH; Sun RF; Lin C; Chen FZ; Mai JT; Liu YX; Xu ZY; Zhang L; Liu J
    Front Cell Infect Microbiol; 2017; 7():226. PubMed ID: 28620588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of antigen-specific T cell responses induced by six novel tuberculosis vaccine candidates.
    Rodo MJ; Rozot V; Nemes E; Dintwe O; Hatherill M; Little F; Scriba TJ
    PLoS Pathog; 2019 Mar; 15(3):e1007643. PubMed ID: 30830940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combinational PRR Agonists in Liposomal Adjuvant Enhances Immunogenicity and Protective Efficacy in a Tuberculosis Subunit Vaccine.
    Hao L; Wu Y; Zhang Y; Zhou Z; Lei Q; Ullah N; Banga Ndzouboukou JL; Lin X; Fan X
    Front Immunol; 2020; 11():575504. PubMed ID: 33117374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced immunogenicity of the tuberculosis subunit Rv0572c vaccine delivered in DMT liposome adjuvant as a BCG-booster.
    Mao L; Xu L; Wang X; Xing Y; Wang J; Zhang Y; Yuan W; Du J; Shi Z; Ma J; Zhang J; Zhang X; Wang X
    Tuberculosis (Edinb); 2022 May; 134():102186. PubMed ID: 35245739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Construction and Evaluation of a Tuberculosis Multistage Vaccine Candidate Based on Recombinant
    Liu T; Liu SJ; Zhou YZ; Zhang YW; Wang C
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 Jan; 51(1):1-6. PubMed ID: 31950781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel multistage antigens ERA005f confer protection against
    Fan X; Zhao X; Wang R; Li M; Luan X; Wang R; Wan K; Liu H
    Front Immunol; 2023; 14():1276887. PubMed ID: 38022539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alarmin IL-33 elicits potent TB-specific cell-mediated responses.
    Villarreal DO; Siefert RJ; Weiner DB
    Hum Vaccin Immunother; 2015; 11(8):1954-60. PubMed ID: 26091147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CpG7909 adjuvant enhanced immunogenicity efficacy in mice immunized with ESAT6-Ag85A fusion protein, but does not confer significant protection against Mycobacterium tuberculosis infection.
    Hu S; Chen H; Ma J; Chen Q; Deng H; Gong F; Huang H; Shi C
    J Appl Microbiol; 2013 Nov; 115(5):1203-11. PubMed ID: 23902541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant BCG coexpressing Ag85B, ESAT-6 and Rv3620c elicits specific Th1 immune responses in C57BL/6 mice.
    Yang E; Lu Y; Xu Y; Liang Q; Wang C; Wang H; Shen H
    Microb Pathog; 2014; 69-70():53-9. PubMed ID: 24726737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptides-Based Vaccine MP3RT Induced Protective Immunity Against
    Gong W; Liang Y; Mi J; Jia Z; Xue Y; Wang J; Wang L; Zhou Y; Sun S; Wu X
    Front Immunol; 2021; 12():666290. PubMed ID: 33981313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.